RM
Ramana Murthy Esapari
About Ramana Murthy Esapari
Data last updated:
Ramana Murthy Esapari is a Director at Sri Sampath Pharmaceuticals Private Limited (since 2021). The company operates in Chemicals. Sri Sampath Pharmaceuticals Private Limited reported revenue of ₹1.45 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Sri Sampath Pharmaceuticals Private Limited U24230TG2021PTC156882 | Director | 11 Nov 2021 | 2021 | ₹1.45 Cr (FY 2025) | Active |
Board colleagues of Ramana Murthy Esapari
| Name | DIN | Company | Designation |
|---|---|---|---|
| Sandhya Narise | 09396186 | Sri Sampath Pharmaceuticals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Ramana Murthy Esapari
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ramana Murthy Esapari
Ramana Murthy Esapari currently holds 1 directorship: Sri Sampath Pharmaceuticals Private Limited (Director, since 11 Nov 2021, revenue ₹1.45 Cr (FY 2025)).
Ramana Murthy Esapari was first appointed on 11 Nov 2021 as Director at Sri Sampath Pharmaceuticals Private Limited.
The current boards of Ramana Murthy Esapari's companies include Sandhya Narise (Sri Sampath Pharmaceuticals Private Limited).